Claro Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Claro Advisors's NVS Position: Q3 2026 in Review
Claro Advisors increased its Novartis (NVS) stake by 51% in Q3 2026, buying an estimated $181K and bringing the position to 3,562 shares worth $508K. The position accounts for 0.05% of the portfolio, ranked #290.
Claro Advisors first reported a position in NVS in Q4 2018 and has held it in 25 quarters since. The position peaked at $533K in Q3 2024. 995 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Claro Advisors held 3,562 shares of Novartis worth $508K as of Q3 2026.
- Claro Advisors bought 1,196 Novartis shares in Q3 2026, an estimated $181K.
- Novartis made up 0.05% of Claro Advisors's portfolio in Q3 2026, its #290 holding.
- Claro Advisors first reported a position in Novartis in Q4 2018 and has held it in 25 quarters since.
- Claro Advisors's Novartis position peaked at $533K in Q3 2024.
- 995 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Claro Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.